Doctor profile · Federal record
Dr. Samuel Balin, M.D., PH.D.
Dermatology Physician (CMS: Dermatology) · Dermatopathology Physician · Springfield, OR
- NPI 1518254481
- Accepts Medicare
- MIPS 91.1 / 100 · 2023
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
860 Beltline RD
Springfield, OR 974771091
(541) 344-4168
fax (458) 201-8510
Credentials & registration
- NPI registered
- June 2011 — 15 yrs on file
- Profile last updated
- December 7, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oregon #MD197986
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518254481. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,272
Distinct HCPCS
10
Medicare allowed
$105,222
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,005 | 173 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 333 | 290 | $85 | |
11102 |
Biopsy of related skin growth, first growth | 254 | 241 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 246 | 221 | $45 | |
11103 |
Biopsy of related skin growth, each additional growth | 107 | 81 | $47 | |
17110 |
Destruction of skin growth, 1-14 growths | 107 | 98 | $106 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 94 | 94 | $104 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 53 | 49 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 35 | 34 | $119 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 20 | 18 | $159 |
In context: peer comparison
Among 1 peers in Springfield Dermatology Physician, average services per provider: 206. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$1,549
Transactions
70
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 15 | $301.19 | |
| Abbvie INC. | 15 | $240.39 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $236.33 | |
| Ucb, INC. | 6 | $184.18 | |
| Genzyme Corporation | 7 | $144.28 | |
| Lilly USA, LLC | 3 | $76.01 | |
| Novartis Pharmaceuticals Corporation | 4 | $70.72 | |
| Pfizer INC. | 3 | $61.50 | |
| Smith+Nephew, INC. | 1 | $48.97 | |
| Regeneron Healthcare Solutions, INC. | 1 | $37.00 | |
| Dermavant Sciences, INC. | 2 | $36.80 | |
| Incyte Corporation | 2 | $35.40 | |
| Organon LLC | 1 | $23.99 | |
| Kyowa Kirin, INC. | 1 | $20.59 | |
| Sun Pharmaceutical Industries INC. | 1 | $18.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
297
Patients
189
Total drug cost
$9,863
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 98 | 68 | $2,687 |
| Triamcinolone Acetonide | Generic | 38 | 28 | $357 |
| Clobetasol Propionate | Generic | 33 | 25 | $2,209 |
| Fluocinonide | Generic | 22 | 16 | $1,797 |
| Clindamycin Phosphate | Generic | 17 | 13 | $358 |
| Econazole Nitrate | Generic | 17 | 14 | $605 |
| Metronidazole | Generic | 17 | 14 | $932 |
| Prednisone | Generic | 16 | 0 | $67 |
| Hydrocortisone | Generic | 15 | 11 | $109 |
| Ciclopirox | Generic | 12 | 0 | $307 |
Frequently asked questions
What is Dr. Samuel Balin's medical specialty?
Dr. Samuel Balin practices Dermatology Physician in Springfield, OR.
Where does Dr. Samuel Balin practice?
Dr. Samuel Balin practices at 860 Beltline RD, Springfield, OR 974771091. Office phone: 5413444168.
What is Dr. Samuel Balin's NPI?
Dr. Samuel Balin's National Provider Identifier (NPI) is 1518254481, issued by NPPES.
Does Dr. Samuel Balin accept Medicare assignment?
Yes. Dr. Samuel Balin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samuel Balin commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.